Senisca

Developer of senotherapeutics that targets the diseases and signs of ageing

placeExeter, England, United Kingdom calendar_todayFounded 2020 groups10 employees language senisca.com

Registered entities

Social engagement

Social engagement: 2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

27 investors on record; lead investors include Emerging Longevity Ventures, R42 Group.

Investor typeCountShare
Venture capital622%
Private equity311%
Other / undisclosed1867%

Recent activity

13 Apr 2026
Event
BioTrinity 2026
Coming soon